Susquehanna International Group, LLP Castle Biosciences Inc Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 9,400 shares of CSTL stock, worth $265,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,400
Previous 35,979
73.87%
Holding current value
$265,738
Previous $783,000
65.77%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CSTL
# of Institutions
199Shares Held
25.9MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$86.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$51.6 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$49.4 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$40.6 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$35.7 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $743M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...